 |
인쇄하기
취소
|
Handok, Novartis Korea strengthen strategic alliance
Handok Pharm said it will co-market new oral treatment released by Novartis, called Galvusmet, a combination of vildagliptin and metformin, here in Korea.
To this end, Handok and Novartis Korea signed an agreement to jointly promote Galvusmet on February 17. Galvusmet has been marketed in 34 countries, including Europe.
Following its first strategic alliance with Galvus in 2008, Handok ha...
To this end, Handok and Novartis Korea signed an agreement to jointly promote Galvusmet on February 17. Galvusmet has been marketed in 34 countries, including Europe.
Following its first strategic alliance with Galvus in 2008, Handok ha...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.